Molina Healthcare (MOH) PT Lowered to $412 at TD Cowen

TD Cowen analyst Gary Taylor lowered the price target on Molina Healthcare (NYSE: MOH) to $412.00 (from $453.00) while maintaining a Buy rating.

The analyst commented, "After incorporating a number of moving parts related to line of business performance and contract gains and losses; we maintain our 2024-25 EPS of 23.79/27.43. We lower our price target from 453 (16.5x 2025E P/E) to 412 (15x 2025E P/E) to reflect lost optionality related to the Florida RFP."

You May Also Be Interested In

• RCM Technologies (RCMT) PT Raised to $45 at Benchmark on Q2 Beat
• Cullinan Oncology Inc. (CGEM) PT Raised to $27 at UBS
• Maxis Bhd (MAXIS:MK) (MAXSF) PT Raised to MYR3.82 at Nomura/Instinet